ASHLEIGH STROBLE: Open Payments
NPI 1568834901 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 19 payments from 5 companies in 2025. Trend: 2023 $898 · 2024 $718 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $414 |
| AstraZeneca Pharmaceuticals LP | 3 | $148 |
| Optinose US, Inc. | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Hikma Pharmaceuticals USA | 1 | $15 |
Products named: DUPIXENT, Xhance, Ryaltris.
Industry payments across OH — which companies pay providers there.
